Last reviewed · How we verify
NCT03319043
Observation of Cough Variant Asthma Treated in Combination of Chanqin Granules.
Phase 1, PHASE2 trial testing Chanqin granules in Cough Variant Asthma in 120 participants. Status unknown.
30 December 2018
Quick facts
| Lead sponsor | Shanghai University of Traditional Chinese Medicine |
|---|---|
| Phase | Phase 1, PHASE2 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 1 November 2017 |
| Primary completion | 30 December 2018 |
| Estimated completion | 30 June 2019 |
| Sites | 1 location across China |
Drugs / interventions tested
- Chanqin granules — full drug profile →
Conditions studied
- Cough Variant Asthma — all drugs for Cough Variant Asthma →
Sponsor
Shanghai University of Traditional Chinese Medicine
Who can join
Adults 18 to 70, any sex, with Cough Variant Asthma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This single-center, randomized, double-blind, placebo-controlled trial was undertaken at an outpatient clinic in Shuguang Hospital. Newly diagnosed cough variant asthma adult patients with the T.C.M. pattern of pathogenic-wind are randomly divided into treatment and control group, with 60 patients in each group. Clinical observation of the Respiratory Impedance and Inflammation in Cough Variant Asthma adults reated in Combination of Chanqin Granules.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03319043
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cough Variant Asthma
Currently open trials in the same condition.
- NCT03105843 — Sensory-Mechanical Responses to Eucapneic Voluntary Hyperventilation and Mannitol · Phase 4 · recruiting
Other Shanghai University of Traditional Chinese Medicine trials
Trials by the same sponsor.
- NCT07331740 — Development and Application of a Parenting Anxiety Intervention Program for Young and Middle-Aged Female Breast Cancer P · NA · not yet recruiting
- NCT07069049 — Electroacupuncture in the Treatment of Patients Undergoing Transperineal Prostate Biopsy Under Local Anesthesia · NA · not yet recruiting
- NCT07245342 — Electroacupuncture for Improving Urinary Incontinence After Radical Prostatectomy · NA · not yet recruiting
- NCT06921512 — TCM Daoyin for Anxiety/Depression: Psychological Effects and Biological Mechanisms · NA · recruiting
- NCT06690606 — EOCRCPred: an AI Model to Predict Survival in EOCRC Patients After Surgery · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03319043 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai University of Traditional Chinese Medicine
- Last refreshed: 24 October 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03319043.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing